These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3765556)
1. [Effect of multiple vaccination against influenza on the specificity of humoral immunity]. Iagodovskiĭ VV; Slepushkin AN; Schastnyĭ EI; Fedorova GI Vopr Virusol; 1986; 31(3):300-3. PubMed ID: 3765556 [TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of inactivated vaccines against influenza]. Fridman EA; Peradze TV Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983 [No Abstract] [Full Text] [Related]
3. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754 [TBL] [Abstract][Full Text] [Related]
4. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis]. Mukhina LP; Bichurina MA; Rozaeva NR Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508 [No Abstract] [Full Text] [Related]
5. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines]. Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907 [TBL] [Abstract][Full Text] [Related]
6. [Characteristics of the immunological and protective effect in the simultaneous and separate use of live and killed influenza vaccines]. Orlov VA; Zhilova GP; Smorodintsev AA; Kozhukhov VM; Ignat'eva GS Vopr Virusol; 1985; 30(3):280-5. PubMed ID: 4049837 [TBL] [Abstract][Full Text] [Related]
8. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S; Süss J; Oehring H; Schmidt J Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540 [TBL] [Abstract][Full Text] [Related]
9. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza]. Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100 [No Abstract] [Full Text] [Related]
10. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. Oxford JS; Schild GC; Potter CW; Jennings R J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040 [TBL] [Abstract][Full Text] [Related]
11. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Luytjes W; Enouf V; Schipper M; Gijzen K; Liu WM; van der Lubben M; Meijer A; van der Werf S; Soethout EC Vaccine; 2012 Jul; 30(35):5262-9. PubMed ID: 22691431 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the effectiveness of inactivated influenza vaccine preparations]. Ismagulov AT; Nurgaliev KN Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):84-7. PubMed ID: 6880484 [TBL] [Abstract][Full Text] [Related]
13. Serum antibodies against native and denaturated hemagglutinin glycoproteins detected by ELISA as correlates of protection after influenza vaccination in healthy vaccinees and in kidney transplant recipients. Grund S; Pietzonka S; Michel S; Adams O J Virol Methods; 2013 Nov; 193(2):558-64. PubMed ID: 23896019 [TBL] [Abstract][Full Text] [Related]
14. Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine. Petrescu A; Steiner N; Trăilescu G; Teodosiu O; Mihăilescu M; Berca C Virologie; 1985; 36(3):187-94. PubMed ID: 4071977 [TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of annual booster inoculations against various influenza serotypes and the procedure for mass vaccination]. Slepushkin AN; Schastnyĭ EI; Obrosova-Serova NP; Kobzeva OB; Tomas LP Vopr Virusol; 1987; 32(6):656-60. PubMed ID: 3445582 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine. Tambyah PA; Wilder-Smith A; Pavlova BG; Barrett PN; Oh HM; Hui DS; Yuen KY; Fritsch S; Aichinger G; Loew-Baselli A; van der Velden M; Maritsch F; Kistner O; Ehrlich HJ Vaccine; 2012 Jan; 30(2):329-35. PubMed ID: 22080174 [TBL] [Abstract][Full Text] [Related]
17. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine. Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864 [TBL] [Abstract][Full Text] [Related]
18. [Humoral immunity to influenza A and B viruses in the blood sera of children younger than 14 in 1981]. Slepushkin AN; Ritova VV; Fedorova GI; Feklisova LV; Obrosova-Serova NP Vopr Virusol; 1983; 28(5):564-7. PubMed ID: 6606903 [TBL] [Abstract][Full Text] [Related]
19. [Cross protection in mice immunized with different anti-influenza preparations]. Rudenko LG; Sosunov AV; Zykov MP Vopr Virusol; 1981; (6):706-9. PubMed ID: 7336695 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in human sera after vaccination with inactivated influenza vaccine. Loza-Tulimowska M; Semkow R; Michalak T; Wilczyński J Acta Virol; 1979 Mar; 23(2):159-61. PubMed ID: 39440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]